U.S. Senate passes bill to trim Big Pharma “patent thickets” (NYSE:TEVA)
2024-07-12
stocknshares The U.S. Senate has passed a bill aimed at easing the entrance of biosimilars and other generic drugs onto the U.S. market by preventing drugmakers from creating “patent thickets” to hinder competition. The bill, called the Affordable Prescriptions for Patients Act, was sponsored by U.S. Sens. John Cornyn (R-TX)Continue Reading
